Notably, in both experimental settings, in vivo administration of recombinant sortilin induced endothelial dysfunction, whereas the lack of S1P3 or gp91phox resulted in a strong protective effect against vascular dysfunction. The gene discussed is S1PR3; the disease is endothelial dysfunction.